HealthEquity, Inc. (NASDAQ:HQY) Receives $119.60 Consensus Target Price from Brokerages

HealthEquity, Inc. (NASDAQ:HQY) has received an average recommendation of “Moderate Buy” from the seventeen ratings firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $119.60.

HQY has been the topic of several analyst reports. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a report on Thursday, December 4th. KeyCorp raised their price target on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a research report on Thursday, January 8th. Barclays initiated coverage on HealthEquity in a research report on Monday, December 8th. They issued an “overweight” rating and a $118.00 price objective for the company. Barrington Research restated an “outperform” rating and issued a $125.00 target price on shares of HealthEquity in a report on Thursday, December 4th. Finally, The Goldman Sachs Group downgraded shares of HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 target price on the stock. in a research note on Friday, January 9th.

HealthEquity Trading Up 0.7%

HQY stock opened at $84.59 on Thursday. The company has a market capitalization of $7.23 billion, a PE ratio of 38.80, a price-to-earnings-growth ratio of 1.21 and a beta of 0.20. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13. HealthEquity has a one year low of $74.07 and a one year high of $116.65. The company’s 50 day moving average price is $95.24 and its two-hundred day moving average price is $94.21.

HealthEquity (NASDAQ:HQY) last released its earnings results on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating the consensus estimate of $0.90 by $0.11. The company had revenue of $322.16 million for the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. As a group, analysts predict that HealthEquity will post 2.32 earnings per share for the current fiscal year.

Insider Activity

In other news, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $94.72, for a total transaction of $142,080.00. Following the completion of the transaction, the executive vice president directly owned 73,979 shares of the company’s stock, valued at approximately $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total value of $1,046,036.55. Following the completion of the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 13,959 shares of company stock valued at $1,344,957. Insiders own 1.50% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently made changes to their positions in HQY. Simplify Asset Management Inc. bought a new stake in shares of HealthEquity in the 3rd quarter worth approximately $1,498,000. Westfield Capital Management Co. LP raised its stake in HealthEquity by 124.6% during the second quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after buying an additional 701,819 shares during the last quarter. Banco Bilbao Vizcaya Argentaria S.A. bought a new stake in HealthEquity in the second quarter worth $492,000. Artisan Partners Limited Partnership boosted its holdings in HealthEquity by 44.8% in the second quarter. Artisan Partners Limited Partnership now owns 621,647 shares of the company’s stock worth $65,124,000 after acquiring an additional 192,252 shares in the last quarter. Finally, First American Bank purchased a new stake in shares of HealthEquity in the third quarter worth $1,633,000. Institutional investors own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.